⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9886596 | 1.00 | — | — | |
| SCHEMBL12361650 | 0.82 | — | — | |
| SCHEMBL386780 | 0.82 | — | — | |
| SCHEMBL386872 | 0.80 | — | — | |
| SCHEMBL11591213 | 0.78 | FAAH (0.50) | — | |
| SCHEMBL385644 | 0.78 | FAAH (0.50) | — | |
| SCHEMBL10864289 | 0.78 | FAAH (0.50) | — | |
| SCHEMBL387807 | 0.78 | FAAH (0.50) | — | |
| SCHEMBL387755 | 0.78 | FAAH (0.50) | — | |
| SCHEMBL11591214 | 0.78 | FAAH (0.50) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11828759-B2 | Method of diagnosis | PETER MACCALLUM CANCER INSTITUTE (AU) | 2023-11-28 | — | — | US | disclosed |
| US-11749377-B2 | Method and electronic system for predicting at least one fitness value of a protein, related computer program product | PEACCEL (FR) | 2023-09-05 | — | — | US | disclosed |
| US-20230227838-A1 | ENHANCED CELL SURVIVAL AGAINST BIOTIC AND ABIOTIC STRESSES THROUGH SALICYLICK ACID-INDUCED NPR1 CONDENSATES | DUKE UNIVERSITY | 2023-07-20 | — | — | US | disclosed |
| US-20230193329-A1 | Compositions and Methods for Recombinant Biosynthesis of Cannabinoids | WILLOW BIOSCIENCES, INC. (CA) | 2023-06-22 | — | — | US | disclosed |
| US-11506670-B2 | Method of genome-wide direct identification of electrophile-sensing targets | CORNELL UNIVERSITY (US) | 2022-11-22 | — | — | US | disclosed |
| US-11008282-B2 | Bicyclic-compounds for use as a medicament, in particular for treatment of parkinson's disease | KOESTER HUBERT (CH) | 2021-05-18 | — | — | US | disclosed |
| US-10837026-B2 | Drought and salt tolerant plants | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2020-11-17 | — | — | US | disclosed |
| US-20180370906-A1 | NOVEL BICYCLIC-COMPOUNDS FOR USE AS A MEDICAMENT, IN PARTICULAR FOR TREATMENT OF PARKINSON'S DISEASE | Koester, Hubert (CH) | 2018-12-27 | — | — | US | disclosed |
| US-20160326542-A1 | DROUGHT AND SALT TOLERANT PLANTS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED | 2016-11-10 | — | — | US | disclosed |
| US-8101650-B2 | Method for treating a immunology-related disease | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2012-01-24 | — | — | US | disclosed |
| EP-1465869-A4 | MODULATORS OF LXR | X CEPTOR THERAPEUTICS INC (US) | 2005-12-28 | — | — | EP | disclosed |
| US-6964976-B2 | Amino alcohol derivatives | SANKYO COMPANY, LIMITED (JP) | 2005-11-15 | — | — | US | disclosed |
| US-20050043386-A1 | Amino alcohol derivatives or phosphonic acid derivatives and pharmaceutical compositions containing these | SANKYO COMPANY, LIMITED (JP) | 2005-02-24 | — | — | US | disclosed |
| EP-1471054-A1 | AMINO ALCOHOL DERIVATIVE OR PHOSPHONIC ACID DERIVATIVE AND MEDICINAL COMPOSITION CONTAINING THESE | Sankyo Company, Limited (JP) | 2004-10-27 | — | — | EP | disclosed |
| EP-1465869-A1 | MODULATORS OF LXR | X-Ceptor Therapeutics, Inc. (US) | 2004-10-13 | — | — | EP | disclosed |
| US-20040132784-A1 | Amino alcohol derivatives | SANKYO COMPANY, LIMITED (JP) | 2004-07-08 | — | — | US | disclosed |
| US-20030236297-A1 | Amino alcohol derivatives | SANKYO COMPANY, LIMITED (JP) | 2003-12-25 | — | — | US | disclosed |
| US-20030181420-A1 | Heterocyclic compounds, in particular N-substituted pyridones for modulating the activity of nuclear receptors | EXELIXIS, INC. | 2003-09-25 | — | — | US | disclosed |
| WO-2003059884-A1 | MODULATORS OF LXR | X-CEPTOR THERAPEUTICS, INC. (US) | 2003-07-24 | — | — | WO | disclosed |
| EP-1300405-A1 | AMINO ALCOHOL DERIVATIVES | Sankyo Company, Limited (JP) | 2003-04-09 | — | — | EP | disclosed |